BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 992546)

  • 1. [Special nosological status of keratoacanthoma. Clinical, histological and comparative Feulgen-cytophotometric studies. 2. Clinical aspects of keratoacanthoma, discussion of Feulgen-cytophotometric findings].
    Ehlers G; Knoth W; Sandritter W
    Fortschr Med; 1976 Oct; 94(30):1732-5. PubMed ID: 992546
    [No Abstract]   [Full Text] [Related]  

  • 2. [Special nosological status of keratoacanthoma. Clinical, histological and comparative Feulgen-cytophotometric studies. 1. Examination material and methods, results].
    Ehlers G; Knoth W; Sandritter W
    Fortschr Med; 1976 Oct; 94(29):1623-9. PubMed ID: 992535
    [No Abstract]   [Full Text] [Related]  

  • 3. [Feulgen-cytophotometric studies on keratoacanthomas].
    Ehlers G; Knoth W; Sandritter W
    Hautarzt; 1974 Mar; 25(3):144-5. PubMed ID: 4847722
    [No Abstract]   [Full Text] [Related]  

  • 4. [Problems in the special nosological position of keratoacanthoma. Clinical, histological and comparative Feulgen-cytophotometric studies. 3. Classification of keratoacanthomas, therapeutic consequences, conclusions].
    Ehlers G; Knoth W; Sandritter W
    Fortschr Med; 1976 Nov; 94(31):1799-804. PubMed ID: 1002085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of granzyme B expression in keratoacanthoma and squamous cell carcinoma.
    Batinac T; Zamolo G; Hadzisejdic I; Zauhar G
    J Dermatol Sci; 2006 Nov; 44(2):109-12. PubMed ID: 16952444
    [No Abstract]   [Full Text] [Related]  

  • 6. [DNA content of precancerous conditions of the skin. A contribution on the question of the special nosological position of cutaneous precancerous conditions].
    Ehlers G
    Fortschr Med; 1971 Sep; 89(27):1042-3. PubMed ID: 4342225
    [No Abstract]   [Full Text] [Related]  

  • 7. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
    Sakiz D; Turkmenoglu TT; Kabukcuoglu F
    Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptotic markers in the differential diagnosis of keratoacanthoma versus squamous cell carcinoma.
    Fernandez-Flores A
    Histopathology; 2007 Jan; 50(2):284-5. PubMed ID: 17222261
    [No Abstract]   [Full Text] [Related]  

  • 9. Disorders of keratinisation.
    Stollery N
    Practitioner; 2007 Sep; 251(1698):60-5. PubMed ID: 17955881
    [No Abstract]   [Full Text] [Related]  

  • 10. [Keratoacanthoma or carcinoma? Histological differential diagnosis].
    Hundeiker M
    Pathologe; 1979 Nov; 1(1):50-2. PubMed ID: 555520
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression of keratin and involucrin in keratoacanthoma: an immunohistochemical aid to diagnosis.
    Ichikawa E; Ohnishi T; Watanabe S
    J Dermatol Sci; 2004 Apr; 34(2):115-7. PubMed ID: 15033195
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cytophotometric measurements of DNA and histone protein content in experimentally induced skin tumors of the rat and hairless mouse. II].
    Rohrbach R; Lau M; Thomas C; Sandritter W
    Beitr Pathol; 1972 May; 146(2):111-21. PubMed ID: 4114484
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell apoptosis as assessed by M30 expression in keratoacanthoma and squamous cell carcinoma.
    Batinac T; Zamolo G; Brumini G; Biljan D; Petranović D; Troselj-Vukić B
    Coll Antropol; 2008 Jun; 32(2):499-504. PubMed ID: 18756900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ki-67 may be useful in differentiating between keratoacanthoma and cutaneous squamous cell carcinoma.
    Scola N; Segert HM; Stücker M; Altmeyer P; Gambichler T; Kreuter A
    Clin Exp Dermatol; 2014 Mar; 39(2):216-8. PubMed ID: 24524559
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.
    Batinac T; Zamolo G; Coklo M; Hadzisejdic I; Stemberger C; Zauhar G
    Pathol Res Pract; 2006; 202(8):599-607. PubMed ID: 16781827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Behavior of keratinosomes in precancerous and pseudoneoplastic conditions and in skin cancers].
    Jakubowicz K; Dabrowski J
    Przegl Dermatol; 1970; 57(5):605-8. PubMed ID: 5475274
    [No Abstract]   [Full Text] [Related]  

  • 17. Subungual keratoacanthoma: analysis of cell proliferation and copy number variation of oncogenes compared with periungual squamous cell carcinoma.
    Honma M; Kato N; Hashimoto M; Takahashi H; Ishida-Yamamoto A; Iizuka H
    Clin Exp Dermatol; 2011 Jan; 36(1):57-62. PubMed ID: 20456385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keratoacanthoma and infundibulocystic squamous cell carcinoma.
    Kossard S; Tan KB; Choy C
    Am J Dermatopathol; 2008 Apr; 30(2):127-34. PubMed ID: 18360115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Cyclooxygenase-2 in Squamous Cell Carcinoma and Keratoacanthoma and its Clinical Significance.
    Hua HK; Jin C; Yang LJ; Tao SQ; Zhu XH
    Cell Biochem Biophys; 2015 Jun; 72(2):475-80. PubMed ID: 25575894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathology of human and experimental skin tumors.
    Klein-Szanto AJ
    Carcinog Compr Surv; 1989; 11():19-53. PubMed ID: 2646016
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.